Viracta Therapeutics, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
VIRX on Nasdaq
Location
2533 S Coast Hwy 101, Suite 210, Cardiff, CA

Insiders trading volume in the past year

Viracta Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
IVor Royston Director $665K Aug 25, 2024
Roger Pomerantz Director $106K Aug 25, 2024
Daniel R. Chevallard CFO and COO $91.9K -$4.35K -4.52% Mar 12, 2024
Lisa Rojkjaer Chief Medical Officer $77.6K Mar 16, 2023
Mark Rothera President and CEO, Director $49.3K +$49.4K Mar 12, 2024
Flavia Borellini Director Jun 20, 2024
Stephen Rubino Director Jun 20, 2024
Jane F. Barlow Director Jun 20, 2024
Thomas E. Darcy Director Jun 20, 2024
Michael Huang Director Jun 9, 2022
Samuel Lafayette Murphy Director Jun 20, 2024
Nicole Onetto Director Jun 9, 2022
Darrel P. Cohen Chief Medical Officer Mar 12, 2024
Melody Burcar Senior VP, Finance Mar 20, 2024
Barry J. Simon Director Jun 20, 2024
Jane Chung Director Jun 20, 2024
Michael E. Faerm Chief Financial Officer May 14, 2024

Recent Insider Transactions by Companies or Individuals for Viracta Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.